- Home
- PRAX vs WGO Comparison
PRAX vs WGO Comparison
Compare PRAX & WGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRAX
- WGO
- Stock Information
- Founded
- PRAX 2015
- WGO 1958
- Country
- PRAX United States
- WGO United States
- Employees
- PRAX N/A
- WGO N/A
- Industry
- PRAX Biotechnology: Pharmaceutical Preparations
- WGO Homebuilding
- Sector
- PRAX Health Care
- WGO Industrials
- Exchange
- PRAX Nasdaq
- WGO Nasdaq
- Market Cap
- PRAX 950.8M
- WGO 893.6M
- IPO Year
- PRAX 2020
- WGO N/A
- Fundamental
- Price
- PRAX $59.22
- WGO $31.66
- Analyst Decision
- PRAX Strong Buy
- WGO Buy
- Analyst Count
- PRAX 10
- WGO 11
- Target Price
- PRAX $101.00
- WGO $39.30
- AVG Volume (30 Days)
- PRAX 399.5K
- WGO 702.9K
- Earning Date
- PRAX 08-12-2025
- WGO 06-25-2025
- Dividend Yield
- PRAX N/A
- WGO 4.30%
- EPS Growth
- PRAX N/A
- WGO N/A
- EPS
- PRAX N/A
- WGO N/A
- Revenue
- PRAX $8,122,000.00
- WGO $2,741,800,000.00
- Revenue This Year
- PRAX N/A
- WGO N/A
- Revenue Next Year
- PRAX $4,434.72
- WGO $5.77
- P/E Ratio
- PRAX N/A
- WGO N/A
- Revenue Growth
- PRAX 270.02
- WGO N/A
- 52 Week Low
- PRAX $26.70
- WGO $28.00
- 52 Week High
- PRAX $91.83
- WGO $65.65
- Technical
- Relative Strength Index (RSI)
- PRAX 78.36
- WGO 50.91
- Support Level
- PRAX $53.89
- WGO $31.08
- Resistance Level
- PRAX $59.10
- WGO $32.83
- Average True Range (ATR)
- PRAX 3.26
- WGO 1.20
- MACD
- PRAX 0.59
- WGO 0.16
- Stochastic Oscillator
- PRAX 88.19
- WGO 52.26
About PRAX Praxis Precision Medicines Inc.
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company has generated three clinical-stage product candidates, ulixacaltamide (formerly known as PRAX-944), vormatrigine (formerly known as PRAX-628), and relutrigine (formerly known as PRAX-562), as well as PRAX-020 which has been in-licensed by UCB Biopharma SRL, or UCB.
About WGO Winnebago Industries Inc.
Winnebago Industries manufactures Class A, B, and C motor homes along with towables, customized specialty vehicles, boats, and parts. Headquartered in Eden Prairie, Minnesota, Winnebago has been producing recreational vehicles since 1958. Revenue was nearly $3 billion in fiscal 2024. Winnebago expanded into towables in 2011 with the acquisition of SunnyBrook and acquired Grand Design in November 2016. Towables made up 83% of the firm's RV unit volume, up from 31% in fiscal 2016. The company's total RV unit volume was 38,796 in fiscal 2024. Winnebago expanded into boating in 2018 with the purchase of Chris-Craft, bought premium motor home maker Newmar in November 2019, and bought Barletta pontoon boats in August 2021. It also is developing electric and autonomous technology.